Paper Details
- Home
- Paper Details
How the Deuteration of Dronedarone Can Modify Its Cardiovascular Profile: In Vivo Characterization of Electropharmacological Effects of Poyendarone, a Deuterated Analogue of Dronedarone.
Author: ChanEric Chun Yong, ChibaKoki, GotoAi, Hagiwara-NagasawaMihoko, Izumi-NakasekoHiroko, KambayashiRyuichi, KondoYoshiki, LeowJacqueline Wen Hui, MatsumotoAkio, NunoiYoshio, SugiyamaAtsushi, VenkatesanGopalakrishnan, YeoZhi Jie
Original Abstract of the Article :
Since deuterium replacement has a potential to modulate pharmacodynamics, pharmacokinetics and toxicity, we developed deuterated dronedarone; poyendarone, and assessed its cardiovascular effects. Poyendarone hydrochloride in doses of 0.3 and 3 mg/kg over 30 s was intravenously administered...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1007/s12012-019-09559-0
データ提供:米国国立医学図書館(NLM)
Deuteration of Dronedarone: Modifying its Cardiovascular Profile
This study investigates the cardiovascular effects of poyendarone, a deuterated analogue of dronedarone, a drug used to treat atrial fibrillation. The study administered different doses of poyendarone to anesthetized dogs and monitored their cardiovascular responses. The researchers found that poyendarone, compared to dronedarone, showed similar pharmacokinetics but reduced beta-adrenoceptor blocking activity and cardio-suppressive effects. The study also found that poyendarone did not significantly inhibit IKr, a potassium channel current, and showed higher atrial selectivity in prolonging the effective refractory period of the atrium versus ventricle.Deuteration: A Potential Approach to Enhancing Drug Efficacy
The study's findings suggest that deuteration, the replacement of hydrogen atoms with deuterium, can be a potential approach to modifying the cardiovascular profile of drugs like dronedarone. The study's results show that poyendarone, the deuterated analogue of dronedarone, exhibits a favorable cardiovascular profile with reduced side effects.Navigating Cardiovascular Health: A Journey Towards Precision Medicine
The desert landscape is a testament to the power of adaptation and resilience. Similarly, navigating cardiovascular health requires a careful approach, considering individual needs and the potential impact of medications. This study highlights the potential of deuteration as a tool for improving the safety and efficacy of cardiovascular drugs, leading us towards a future of personalized medicine.Dr. Camel's Conclusion
This study showcases the exciting possibilities of drug design and development. Deuteration, a subtle modification to a drug's structure, can have a significant impact on its pharmacological properties. This research offers a promising glimpse into the future of drug development, where tailored treatments can be designed to address individual needs and minimize side effects.Date :
- Date Completed 2021-01-18
- Date Revised 2021-01-18
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.